Return to Newsletter With more than $90 million of investment capital currently under management, i2E has been a primary source of concept, seed stage, start-up and early growth investment capital for Oklahoma’s emerging small businesses for two decades. Our rigorous investment process has a reputation for producing companies that are well positioned for success in the marketplace. Read more
News
By Scott Meacham As i2E has been closing our latest round of new investments over the last few weeks, I am reminded of how in the startup world and the venture industry, investment events attract attention. I don’t usually write about investment events. The celebratory milestones have already occurred over the weeks, months, and yearsRead more
By Scott Meacham Lupus is chronic autoimmune condition with devastating effects. The disease is difficult to diagnose. Its course is unpredictable. There is no cure and few FDA-approved medications. Patients who have lupus live with its impact for the rest of their lives. At times, the disease flares up and gets worse; in remission, symptomsRead more
By Jim Stafford Copyright © 2019, The Oklahoman Five patients are waiting to see their doctor, each displaying different symptoms. One has a bright rash on her face. Another is suffering from arthritis. Still another has kidney failure, while the fourth patient suffers from heart problems and the fifth is fatigued all the time. TurnsRead more
By Mary Chapman Lupus News Today Copyright © 2013-2018 All rights reserved. Completion of a second round of funding could help bring closer to market Progentec Diagnostics‘ new tool for predicting lupus flares and a biomarker-based index that monitors underlying disease activity. Funding for Progentec’s biomarker-based diagnostic testing was led by venture capital outfits i2ERead more
By Journal Record Staff Courtesy of the Journal Record OKLAHOMA CITY – Progentec Diagnostics Inc. has completion a second round of funding led by i2E, along with Chicago-based OCA Ventures and NMC Lifesciences, a health care provider. The funding will help bring Oklahoma City-based Progentec’s tool for identifying lupus flare-ups and a biomarker-based disease-activity indexRead more
– New funding brings lupus-detection tools closer to commercialization – Acquisition of LupusCorner marks a step forward in developing a first-in-class lupus-management platform OKLAHOMA CITY, Nov. 1, 2018 /PRNewswire/ — Progentec Diagnostics, Inc. (“Progentec”), a leader in the development of technological innovations in the field of diagnostics, today announced the completion of a second roundRead more
By CAROLINA HENRIQUES Lupas News Today Progentec Diagnostics is closer to marketing a new set of tools for predicting lupus flares after obtaining $1.25 million in financing. The Oklahoma Medical Research Foundation created the technology the company is using. Progentec is collaborating with Dr. Judith James, a lupus researcher who developed the technology, to refineRead more
By Scott Meacham Copyright © The Oklahoma Publishing Co. Every year around the middle of October, I start writing in my head at least one holiday-focused column before the end of the year. I try to jot down a few ideas, feeling good that I have started well in advance, and then the whirlwind ofRead more
By Paula Burkes Copyright © 2017, The Oklahoma Publishing Co. Scientists don’t yet know why some 1.5 million Americans have lupus, an autoimmune disease in which the body attacks its own healthy tissues. Symptoms surface mostly in women ages 16 to 34 and vary from rashes and joint pain to deadly organ failure. Physician-scientist JudithRead more
By Scott Meacham Copyright © 2017, The Oklahoma Publishing Co. Over the last year, Progentec Diagnostics, a startup that is focused on developing breakthrough diagnostics, has made significant progress on a diagnostic test to identify patients at increased risk for flare in lupus. Lupus is a viciously painful disease that generally surfaces in women inRead more
I get really excited when I see an Oklahoma startup improving the lives of people who have incurable debilitating disease. That’s the story of Progentec Diagnostics, a startup that is focused on developing breakthrough diagnostics. The firm’s initial focus is on developing a diagnostic test to identify patients at increased risk for flare in lupus, an incurable autoimmune disease that afflicts 1.5 million patients in the U.S.
